Loading...

Emerging Markets And Digital Transformation Will Enable Long-Term Stability

Published
23 Feb 25
Updated
11 Dec 25
Views
609
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
46.5%
7D
-1.4%

Author's Valuation

UK£44.715.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 11 Dec 25

Fair value Increased 2.48%

BATS: Future Returns Will Reflect Smoke-Free Shift And Deleveraging Focus

Analysts have raised their price target for British American Tobacco by approximately $1.08, citing modest improvements in projected revenue growth, profit margins, and future valuation multiples that collectively support a slightly higher fair value estimate.

What's in the News

  • Issued 2025 guidance for around 2% group revenue growth at constant rates, with mid single digit revenue growth expected from New Category products, signaling modest acceleration in smoke-free offerings (company guidance).
  • Reaffirmed 2026 mid term growth algorithm of 3% to 5% revenue growth, but indicated results are now expected toward the lower end of that range, underscoring a cautious outlook in core markets (company guidance).
  • Announced plans to sell between 7% and up to its full 15.3% stake in ITC Hotels Limited via an accelerated bookbuild, as BAT exits a non strategic holding to streamline the portfolio (company statement).
  • Stated that proceeds from the ITC Hotels stake sale will be used to move leverage into a target range of 2 to 2.5 times adjusted net debt to adjusted EBITDA by the end of 2026, highlighting ongoing balance sheet de risking (company statement).

Valuation Changes

  • The Fair Value Estimate has risen slightly from $43.63 to about $44.71 per share, reflecting a modestly higher intrinsic valuation.
  • The Discount Rate has fallen marginally from approximately 8.47% to about 8.41%, indicating a slightly lower perceived risk profile in the cash flow discounting.
  • The Revenue Growth Assumption has increased moderately from roughly 2.36% to about 2.73% per year, pointing to a somewhat stronger long term growth outlook.
  • The Net Profit Margin Forecast has edged up from around 29.72% to about 29.79%, implying a small improvement in expected operating profitability.
  • The Future P/E Multiple has risen slightly from about 14.80x to approximately 14.94x, suggesting a modestly higher valuation multiple applied to expected earnings.

Key Takeaways

  • Expansion of reduced-risk products and innovation in emerging markets supports global growth, margin improvement, and earnings resilience.
  • Digital transformation and cost efficiency drive capital allocation, cash generation, and sustained shareholder returns.
  • Regulatory, market, and societal pressures threaten revenue stability, margin growth, and long-term business sustainability as BAT transitions from traditional cigarettes to newer product categories.

Catalysts

About British American Tobacco
    Provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States.
What are the underlying business or industry changes driving this perspective?
  • The rapid growth and further penetration of Modern Oral (Velo) and Heated Products, especially in emerging markets with rising disposable incomes, positions BAT well to tap into geographic revenue diversification and stabilize global volumes, supporting top-line growth in the medium to long term.
  • Strong uptake and premiumization of reduced-risk new category products (Modern Oral, Heated, and Vapour), combined with successful innovation rollouts (Velo Plus, glo Hilo, Vuse Ultra), are driving higher contribution margins and gross margins, setting the stage for structural net margin and earnings expansion as these products scale.
  • Digital transformation, operational streamlining, and targeted cost savings programs (e.g., Fit2Win, global supply chain efficiencies) are releasing capital for reinvestment in high-return growth opportunities and innovation, protecting operating margins and supporting future free cash flow growth.
  • Proactive adaptation to evolving regulatory environments (e.g., greater enforcement on illicit vapour, prioritizing science-backed engagement) and strategic resource allocation to profitable/favorable markets underpin management's ability to safeguard market share and drive resilience in both existing and new product segments, with the expected effect of stabilizing earnings.
  • Ongoing strong cash generation, disciplined deleveraging, and a commitment to progressive dividends and share buybacks enhance total shareholder return potential and underpin long-term financial flexibility, likely supporting sustained EPS growth and valuation re-rating as execution continues.

British American Tobacco Earnings and Revenue Growth

British American Tobacco Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming British American Tobacco's revenue will grow by 2.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 11.9% today to 30.0% in 3 years time.
  • Analysts expect earnings to reach £8.3 billion (and earnings per share of £3.94) by about September 2028, up from £3.0 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as £7.4 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 13.7x on those 2028 earnings, down from 29.3x today. This future PE is lower than the current PE for the US Tobacco industry at 19.4x.
  • Analysts expect the number of shares outstanding to decline by 0.38% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.27%, as per the Simply Wall St company report.

British American Tobacco Future Earnings Per Share Growth

British American Tobacco Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Escalating regulatory risk and fiscal headwinds in key markets-such as flavor bans, strict enforcement inconsistency, and increased excise taxes (e.g., Bangladesh, Australia, Canada, and Malaysia)-continue to impact legal product availability and sales, particularly in vapour, which could erode BAT's revenues and operating margins over time.
  • Persistent illicit trade in vapour and combustible products, especially in the U.S. and Canada, undermines BAT's legal market share and limits its ability to grow volumes and revenues from both traditional and new category products, thereby putting pressure on revenue growth and earnings stability.
  • Ongoing secular declines in combustible cigarette volumes, despite near-term stabilization and pricing offsets, represent a fundamental risk to BAT's main revenue base (still >70% from combustibles), potentially leading to long-term revenue contraction and margin pressure as regulatory and public health pressure increases.
  • High and rising investment in new categories (Modern Oral, Heated, Vape) is required to offset declines in traditional products, yet these segments face intense competition, evolving regulatory hurdles, and inconsistent execution-risking lower-than-expected returns on investment, reduced profitability, and more volatile earnings.
  • ESG-related investor aversion and growing health consciousness may limit BAT's access to certain pools of institutional capital, suppress share valuations, and shrink the overall addressable market over the longer term, affecting both net margins and enterprise value.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of £41.292 for British American Tobacco based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £52.0, and the most bearish reporting a price target of just £30.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be £27.5 billion, earnings will come to £8.3 billion, and it would be trading on a PE ratio of 13.7x, assuming you use a discount rate of 8.3%.
  • Given the current share price of £40.91, the analyst price target of £41.29 is 0.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on British American Tobacco?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives